Effects of a one week multidisciplinary inpatient self-management programme for patients with fibromyalgia: a randomised controlled trial

Bente Hamnes, Petter Mowinckel, Ingvild Kjeken, Kåre B Hagen, Bente Hamnes, Petter Mowinckel, Ingvild Kjeken, Kåre B Hagen

Abstract

Background: Self-management programmes (SMP) are recommended for patients with fibromyalgia. The purpose of this study was to evaluate effects of a one week multidisciplinary inpatient self-management programme on psychological distress, skills as a consumer of health services, self-efficacy, and functional and symptomatic consequences of fibromyalgia (FM).

Methods: A randomised controlled two-armed, assessor-blinded trial with three-week follow-up to evaluate SMP. Primary outcomes were the General Health Questionnaire (GHQ-20) and the Effective Musculoskeletal Consumer Scale (EC-17), while secondary outcomes included the Fibromyalgia Impact Questionnaire (FIQ) and Self-efficacy scales for pain, function and symptoms (ASES).

Results: 150 patients with FM were randomised to one week one SMP (n = 75) or to a waiting list control group (n = 75). Of these, 58 participants in the treatment group and 60 in the control group completed the study. At three weeks' follow up there was a significant difference in EC-17 (0-100) in favour of the treatment group (mean difference 4.26, 95 CI 0.8 to 7.7, p = 0.02). There were no differences between the groups for any of the other outcomes.

Conclusion: This study shows that in patients with FM the SMP had no effect on psychological distress, functional and symptomatic consequences and self-efficacy, except for a small short-term effect on skills and behaviour that are important for managing and participating in health care (EC-17). Clinical Trials.gov Id: NCT01035125.

Trial registration: Clinical Trials.gov Id: NCT01035125.

Figures

Figure 1
Figure 1
Flow diagram of the participants in the randomised trial.

References

    1. Hauser W, Eich W, Herrmann M, Nutzinger DO, Schiltenwolf M, Henningsen P. Fibromyalgia syndrome: classification, diagnosis, and treatment. Dtsch Arztebl Int. 2009;106:383–391.
    1. Hoffman DL, Dukes EM. The health status burden of people with fibromyalgia: a review of studies that assessed health status with the SF-36 or the SF-12. Int J Clin Pract. 2008;62:115–126.
    1. Lempp HK, Hatch SL, Carville SF, Choy EH. Patients' experiences of living with and receiving treatment for fibromyalgia syndrome: a qualitative study. BMC Musculoskelet Disord. 2009;10:124. doi: 10.1186/1471-2474-10-124.
    1. Kool MB, van MH, Boeije HR, Geenen R. Understanding the lack of understanding: invalidation from the perspective of the patient with fibromyalgia. Arthritis Rheum. 2009;61:1650–1656. doi: 10.1002/art.24922.
    1. Album D, Westin S. Do diseases have a prestige hierarchy? A survey among physicians and medical students. Soc Sci Med. 2008;66:182–188. doi: 10.1016/j.socscimed.2007.07.003.
    1. Carville SF, Arendt-Nielsen S, Bliddal H, Blotman F, Branco JC, Buskila D. et al.EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis. 2008;67(4):536–541.
    1. Adams N, Sim J. Rehabilitation approaches in fibromyalgia. Disabil Rehabil. 2005. pp. 711–723.
    1. Burckhardt CS. Multidisciplinary approaches for management of fibromyalgia. Curr Pharm Des. 2006;12:59–66. doi: 10.2174/138161206775193217.
    1. Goldenberg DL. Multidisciplinary modalities in the treatment of fibromyalgia. J Clin Psychiatry. 2008;69(Suppl 2):30–34.
    1. Goldenberg DL, Burckhardt C, Crofford L. Management of fibromyalgia syndrome. JAMA. 2004;292:2388–2395. doi: 10.1001/jama.292.19.2388.
    1. Barlow J, Wright C, Sheasby J, Turner A, Hainsworth J. Self-management approaches for people with chronic conditions: a review. Patient Educ Couns. 2002;48:177–187. doi: 10.1016/S0738-3991(02)00032-0.
    1. Iversen MD, Hammond A, Betteridge N. Self-management of rheumatic diseases: state of the art and future perspectives. Ann Rheum Dis. 2010;69:955–963. doi: 10.1136/ard.2010.129270.
    1. Haugli L, Steen E, Laerum E, Nygard R, Finset A. Learning to have less pain - is it possible? A one-year follow-up study of the effects of a personal construct group learning programme on patients with chronic musculoskeletal pain. Patient Educ Couns. 2001;45:111–118. doi: 10.1016/S0738-3991(00)00200-7.
    1. Zangi HA, Finset A, Steen E, Mowinkel P, Hagen KB. The effects of a vitality training programme on psychological distress in patients with inflammatory rheumatic diseases and fibromyalgia: a 1-year follow-up. Scand J Rheumatol. 2009;38:231–232. doi: 10.1080/03009740802474680.
    1. Hamnes B, Hauge MI, Kjeken I, Hagen KB. 'I have come here to learn how to cope with my illness, not to be cured': A qualitative study of patient expectations prior to a one-week self-management programme. Musculoskeletal Care. 2011;9:200–210. doi: 10.1002/msc.212.
    1. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL. et al.The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum. 1990;33:160–172. doi: 10.1002/art.1780330203.
    1. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: the new medical research council guidance. BMJ. 2008;337:a1655. doi: 10.1136/bmj.a1655.
    1. Hiim H, Hippe E. Undervisningsplanlegging for yrkeslærere. Gyldendal Akademiske, Oslo, Norge; 1989.
    1. Hiim H. In: The quality of practitioner research: reflections on the position of the researcher and the researched. Ponte P, Smith B, editor. Sense Publishers, Rotterdam; 2007. A strategy for practice-based education and research.
    1. Burckhardt CS. Educating patients: self-management approaches. Disabil Rehabil. 2005;27:703–709. doi: 10.1080/09638280400009097.
    1. Bandura A. Self-efficacy, The Exercise ofControl. W.H. Freeman and Company, New York; 1997.
    1. Lazarus RS. Coping with the stress of illness. WHO Reg Publ Eur Ser. 1992;44:11–31.
    1. Feste C, Anderson RM. Empowerment: from philosophy to practice. Patient Educ Couns. 1995;26:139–144. doi: 10.1016/0738-3991(95)00730-N.
    1. Shearer NB. Health empowerment theory as a guide for practice. Geriatr Nurs. 2009;30:4–10.
    1. Tang TS, Funnell MM, Brown MB, Kurlander JE. Self-management support in "real-world" settings: an empowerment-based intervention. Patient Educ Couns. 2010;79:178–184. doi: 10.1016/j.pec.2009.09.029.
    1. Benjamin S, Morris S, McBeth J, Macfarlane GJ, Silman AJ. The association between chronic widespread pain and mental disorder: a population-based study. Arthritis Rheum. 2000;43:561–567. doi: 10.1002/1529-0131(200003)43:3<561::AID-ANR12>;2-O.
    1. Finset A, Anke AW, Hofft E, Roaldsen KS, Pillgram-Larsen J, Stanghelle JK. Cognitive performance in multiple trauma patients 3 years after injury. Psychosom Med. 1999;61:576–583.
    1. Malt UF, Mogstad TE, Refnin IB. [Goldberg's General Health Questionnaire] Tidsskr Nor Laegeforen. 1989;109:1391–1394.
    1. Pembroke TP, Rasul F, Hart CL, Davey SG, Stansfeld SA. Psychological distress and chronic obstructive pulmonary disease in the Renfrew and Paisley [MIDSPAN) study. J Epidemiol Community Health. 2006;60:789–792. doi: 10.1136/jech.2005.042150.
    1. Malt UF. The validity of the general health questionnaire in a sample of accidentally injured adults. Acta Psychiatr Scand Suppl. 1989;355:103–112.
    1. Goldberg D, Williams P. A user's guide to the General Health Questionnaire. 1-129. NFER-Nelson Publishing Compan, Winsor (UK); 1988. Ref Type: Report.
    1. McDowell I. Measuring Health. A guide to Rating Scales and Questionnaires. 3. Oxford University Press, New York; 2006. Psychological well-being; pp. 206–272.
    1. Kristjansson E, Tugwell PS, Wilson AJ, Brooks PM, Driedger SM, Gallois C. et al.Development of the effective musculoskeletal consumer scale. J Rheumatol. 2007;34:1392–1400.
    1. Santesso N, Rader T, Wells GA, O'Connor AM, Brooks PM, Driedger M. et al.Responsiveness of the effective consumer scale (EC-17) J Rheumatol. 2009;36:2087–2091. doi: 10.3899/jrheum.090363.
    1. Hamnes B, Garratt A, Kjeken I, Kristjansson E, Hagen KB. Translation, data quality, reliability, validity and responsiveness of the Norwegian version of the effective musculoskeletal consumer scale (EC-17) BMC Musculoskelet Disord. 2010;11:21. doi: 10.1186/1471-2474-11-21.
    1. Lorig K, Chastain RL, Ung E, Shoor S, Holman HR. Development and evaluation of a scale to measure perceived self-efficacy in people with arthritis. Arthritis Rheum. 1989;32:37–44. doi: 10.1002/anr.1780320107.
    1. Burckhardt CS, Clark SR, Bennett RM. The fibromyalgia impact questionnaire: development and validation. J Rheumatol. 1991;18:728–733.
    1. Hedin PJ, Hamne M, Burckhardt CS, Engstrom-Laurent A. The Fibromyalgia Impact Questionnaire, a Swedish translation of a new tool for evaluation of the fibromyalgia patient. Scand J Rheumatol. 1995;24:69–75. doi: 10.3109/03009749509099287.
    1. Bennett R. The Fibromyalgia Impact Questionnaire [FIQ): a review of its development, current version, operating characteristics and uses. Clin Exp Rheumatol. 2005;23:S154–S162.
    1. Fleiss JL. Statistical methods for rates and proportions. 2. John Wiley, New York; 1981.
    1. Belsley DA, Kuh E, Welch RE. Regression diagnostic: Identifying Influential Data and Sources of collinearity. John Wiley & Sons Inc, Hoboken, New Jersey; 1980. Detecting influential observations and outliers; pp. 6–50.
    1. Statistical Analysis System SAS. [9.1.3] SAS Institute Inc, Cary, North Carolina, USA; 2004.
    1. Van KS, Effting M, Kraaimaat FW, Van LW, Van HT, Cats H. et al.Cognitive-behavioural therapies and exercise programmes for patients with fibromyalgia: state of the art and future directions. Ann Rheum Dis. 2007;66:571–581. doi: 10.1136/ard.2006.054692.
    1. Goldenberg DL, Clauw DJ, Fitzcharles MA. New concepts in pain research and pain management of the rheumatic diseases. Semin Arthritis Rheum. 2011;41:319–334. doi: 10.1016/j.semarthrit.2011.04.005.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する